Doc fired for industry ties sues hospital

A former Cleveland Clinic physician is suing the hospital for firing him over conflicts of interest, the Wall Street Journal linkurl:reports.;http://online.wsj.com/article_print/SB119699329567216612.html Jay Yadav, who was fired last year from his post as head of the vascular intervention unit, invented a device to prevent blockages caused by neck stents. He tested the device at the Cleveland Clinic, and received shares from the company that commercialized it. However, he insists that he reveal

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A former Cleveland Clinic physician is suing the hospital for firing him over conflicts of interest, the Wall Street Journal linkurl:reports.;http://online.wsj.com/article_print/SB119699329567216612.html Jay Yadav, who was fired last year from his post as head of the vascular intervention unit, invented a device to prevent blockages caused by neck stents. He tested the device at the Cleveland Clinic, and received shares from the company that commercialized it. However, he insists that he revealed his financial stakes to the hospital as early as 2002, as required, according to the Journal. He alleged in the suit that he was "scapegoated" when the hospital came under pressure of an linkurl:investigation;http://www.cleveland.com/news/plaindealer/index.ssf?/base/cuyahoga/1197020172287340.xml&coll=2 by the Cleveland Plain Dealer. Yadav also cited similar industry ties among several staff members including the Clinic's CEO, Delos "Toby" Cosgrove. The hospital denied the allegations in a statement provided to the Journal. The dispute highlights the prevalence of financial interests among clinicians: A recent linkurl:study;http://www.the-scientist.com/blog/display/53722/ found that 60% of physicians surveyed at 140 academic medical centers had industry ties.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies